Alkami CEO buys 45,000 shares at $19.45; holds 841,563
Alkami Technology (ALKT) disclosed that its Chief Executive Officer and director, Alex Shootman, acquired 45,000 shares of common stock on November 7, 2025 at $19.45 per share.
Rhea-AI Filing Summary
Alkami Technology (ALKT) disclosed that its Chief Executive Officer and director, Alex Shootman, acquired 45,000 shares of common stock on November 7, 2025 at $19.45 per share.
After this transaction, Shootman beneficially owned 841,563 shares, held directly. The acquisition was from the issuer in a transaction approved by the company’s board of directors.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 45,000 | $19.45 | $875K |
Footnotes (1)
- F1. Represents an acquisition by the Reporting Person from the Issuer in a transaction approved by the Issuer's board of directors.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ALKT report about insider activity?
CEO and director Alex Shootman acquired 45,000 shares of Alkami common stock on 11/07/2025.
Was the transaction approved by Alkami’s board?
Yes. The filing states the transaction was approved by the board of directors.
Did the filing include any derivative securities for ALKT?
No derivative securities were reported in Table II.
What form reported this ALKT insider transaction?
A Form 4 insider ownership report.
AI-generated analysis. How Rhea-AI works. Not financial advice.